Among seven testis-specific molecular markers, SPEM1 appears to have a significant clinical value for prediction of sperm retrieval in azoospermic men

Andrology. 2018 Nov;6(6):890-895. doi: 10.1111/andr.12528. Epub 2018 Jul 27.

Abstract

Background: To achieve sperm retrieval in azoospermic men, predicting the success rate seems to be necessary.

Objectives: In the present study we aimed to assess expression of seven molecular markers [ESX1, DAZ, DAZL (pre-meiotic markers), ZMYND15, PRM1, TNP1, and SPEM1 (post-meiotic markers)] to predict the success of sperm retrieval.

Materials and methods: In this study, 63 azoospermic men [16 OA (obstructive azoospermia) and 47 NOA (nonobstructive azoospermia)] undergoing testicular tissue microdissection (micro-TESE) for intracytoplasmic sperm injection (ICSI). Expression levels of these target genes were determined by real-time reverse transcription polymerase chain reaction using the DDCt method, and efficacy of each gene was compared by receiver operating characteristic (ROC) curve analysis.

Results: Expression of post-meiotic transcripts significantly decreases in NOA and its subgroups (SCOS: Sertoli cell only syndrome, MA: maturation arrest, and HS: hypospermatogenesis) with spermatogenic failure compared to normal spermatogenesis (OA), with an exception of ZMYND15 for the HS group. These findings suggest the differential expression of the post-meiotic ZMYND15 marker is in accordance with histological findings and can discriminate HS from SCOS and MA. Post-meiotic markers were significantly reduced in negative vs. positive sperm retrieval groups.

Discussion and conclusion: Among the seven markers, SPEM1 had the best positive prediction power (96%) and negative prediction power (85%) at a 0.086 cutoff with the area under the curve (AUC) of 0.91 for receiver operating characteristic 4 (ROC) to predict the micro-TESE outcome.

Keywords: azoospermia; microdissection testicular sperm extraction; post-meiotic marker; pre-meiotic marker; sperm retrieval.

Publication types

  • Comparative Study

MeSH terms

  • Azoospermia / enzymology
  • Azoospermia / genetics*
  • Azoospermia / physiopathology
  • Azoospermia / therapy
  • Clinical Decision-Making
  • DNA (Cytosine-5-)-Methyltransferases / genetics*
  • Genetic Markers
  • Humans
  • Male
  • Membrane Proteins / genetics*
  • Predictive Value of Tests
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sperm Injections, Intracytoplasmic
  • Sperm Maturation
  • Sperm Retrieval*
  • Spermatogenesis / genetics*
  • Spermatozoa / enzymology*
  • Testis / enzymology*
  • Testis / physiopathology

Substances

  • Genetic Markers
  • Membrane Proteins
  • SPEM1 protein, human
  • DNA (Cytosine-5-)-Methyltransferases